CEL-SCI Corporation (CVM)
$1.83-5.67%Close
BUYCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $13M
- Beta
- 0.59
- P/E (TTM)
- -1.06
- Short % float
- 9.39%
- Days to cover
- 4.1
- SI change
- -4.3%
- 1W
- -24.38%
- 1M
- +22.82%
- vs SPY 1W
- -24.80%
- vs SPY 1M
- +20.76%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CVM?
- LOPJLB’s latest quantitative signal on CEL-SCI Corporation (CVM) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is CVM in?
- CEL-SCI Corporation (CVM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does CEL-SCI Corporation (CVM) do?
- CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy candidate, Multikine, is currently undergoing Phase III clinical trials for the treatment of head and neck cancer. The company also develops and holds the patent for its preclinical Ligand Epitope Antigen Presentation System (LE…